Dr. James J. Devoursney, MD

Dr. Devoursney practices at Boynton Beach Skin Institute in Boynton Beach, Florida.

Dr. Devoursney's NPI, 1871696021, was assigned on September 6, 2006. Dr. Devoursney graduated from University of Miami, Miller School of Medicine in 1996. Dr. Devoursney holds Florida license ME80429.

Dr. Devoursney's primary practice is Boynton Beach Skin Institute, at 7740 Boynton Beach Blvd, Boynton Beach, FL 33437-3804. The practice phone is (561) 752-5592.

Dr. Devoursney's primary practice is Boynton Beach Skin Institute in Boynton Beach, Florida. The medical group on file is Boynton Beach Skin. Dmand AI also links Dr. Devoursney to 4 more home health agencies, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devoursney practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Devoursney's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Devoursney is board certified in dermatology by the American Board of Dermatology. Dr. Devoursney is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and hives among the conditions Dr. Devoursney treats.

CMS data shows 10,185 Medicare services from Dr. Devoursney across 38 procedure codes in 2024, for 1,230 Medicare patients. Medicare paid $859,281 for them. Every service was in an office.

CMS counts 1,230 Medicare patients who saw Dr. Devoursney in 2024. The largest group is 75 to 84, with 558 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.49, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Devoursney's median patient age at 78, with 53% women.

In 2024, Dr. Devoursney wrote 1,601 Medicare Part D claims for 676 patients. 95% of them were for generic drugs. CMS names the drug for 1,422 of them, across 27 drugs with 11 or more claims each, at $35,144 in total drug cost. In 2023, CMS named 1,408 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Devoursney for performance year 2024, reported as part of a group. Dr. Devoursney accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,582 procedures of removal of skin lesions by Dr. Devoursney, more than 97% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Devoursney. Dr. Devoursney's most frequent co-author is Keyvan Nouri, MD.

CMS Open Payments shows 317 general payments to Dr. Devoursney from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Abbvie Inc. paid the most, $1,004.

Dmand AI lists 1 award for Dr. Devoursney.

Dr. Devoursney graduated from University of Miami, Miller School of Medicine in 1996. Dr. Devoursney is a member of AAD.

Dr. Devoursney is in network with 9 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.